Replimune Group Inc (REPL)
7.01
+0.06
(+0.86%)
USD |
NASDAQ |
May 06, 16:00
7.005
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Total Assets (Quarterly): 532.93M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 532.93M |
| September 30, 2023 | 562.40M |
| June 30, 2023 | 603.89M |
| March 31, 2023 | 646.59M |
| December 31, 2022 | 678.55M |
| September 30, 2022 | 436.10M |
| June 30, 2022 | 459.43M |
| March 31, 2022 | 461.19M |
| December 31, 2021 | 485.28M |
| September 30, 2021 | 503.46M |
| June 30, 2021 | 523.72M |
| March 31, 2021 | 543.10M |
| Date | Value |
|---|---|
| December 31, 2020 | 559.20M |
| September 30, 2020 | 314.24M |
| June 30, 2020 | 329.58M |
| March 31, 2020 | 234.10M |
| December 31, 2019 | 250.42M |
| September 30, 2019 | 151.44M |
| June 30, 2019 | 143.54M |
| March 31, 2019 | 154.33M |
| December 31, 2018 | 152.19M |
| September 30, 2018 | 153.82M |
| June 30, 2018 | 59.29M |
| March 31, 2018 | 65.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
143.54M
Minimum
Jun 2019
678.55M
Maximum
Dec 2022
443.11M
Average
485.28M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Esperion Therapeutics Inc | 205.80M |
| Gossamer Bio Inc | 311.92M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 111.39M |
| Shareholders Equity (Quarterly) | 421.54M |